Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia.

Tavernier-Tardy E, Cornillon J, Campos L, Flandrin P, Duval A, Nadal N, Guyotat D.

Leuk Res. 2009 Jun;33(6):764-8. doi: 10.1016/j.leukres.2008.10.014. Epub 2008 Nov 29.

PMID:
19042019
2.

CXCR4 is a prognostic marker in acute myelogenous leukemia.

Spoo AC, Lübbert M, Wierda WG, Burger JA.

Blood. 2007 Jan 15;109(2):786-91. Epub 2006 Aug 3.

3.

Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype.

Konoplev S, Rassidakis GZ, Estey E, Kantarjian H, Liakou CI, Huang X, Xiao L, Andreeff M, Konopleva M, Medeiros LJ.

Cancer. 2007 Mar 15;109(6):1152-6.

4.

[Prognostic significance of leukemia-associated phenotype in correlation with other biologic markers in acute myeloid leukemia patients].

Dăscălescu A, Zlei M, Grigore G, Dănăila C, Jitaru D, Carasevici E.

Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1176-81. Romanian.

PMID:
20191895
5.

VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia.

Bae MH, Oh SH, Park CJ, Lee BR, Kim YJ, Cho YU, Jang S, Lee JH, Kim N, Park SH, Lim JH, Seo EJ, Lee KH.

Ann Hematol. 2015 Oct;94(10):1631-8. doi: 10.1007/s00277-015-2442-8. Epub 2015 Jul 10.

PMID:
26155911
6.

High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia.

Tang R, Hirsch P, Fava F, Lapusan S, Marzac C, Teyssandier I, Pardo J, Marie JP, Legrand O.

Blood. 2009 Oct 1;114(14):2993-3000. doi: 10.1182/blood-2009-05-223115. Epub 2009 Jul 30.

7.

Relationship between CXC chemokine receptor 4 expression and prognostic significance in acute myeloid leukemia.

Cao T, Ye Y, Liao H, Shuai X, Jin Y, Su J, Zheng Q.

Medicine (Baltimore). 2019 Jun;98(23):e15948. doi: 10.1097/MD.0000000000015948.

8.

CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.

Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, Nishinaka-Arai Y, Tokumasu M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S.

Pediatr Blood Cancer. 2016 Aug;63(8):1394-9. doi: 10.1002/pbc.26035. Epub 2016 May 2.

PMID:
27135782
9.

Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML.

Terwijn M, Feller N, van Rhenen A, Kelder A, Westra G, Zweegman S, Ossenkoppele G, Schuurhuis GJ.

Eur J Cancer. 2009 Jun;45(9):1692-9. doi: 10.1016/j.ejca.2009.02.021. Epub 2009 Mar 25.

PMID:
19321337
10.

High CXCR4 and low VLA-4 expression predicts poor survival in adults with acute lymphoblastic leukemia.

Ko SY, Park CJ, Park SH, Cho YU, Jang S, Seo EJ, Kim N, Kim DY, Koh KN, Im HJ, Seo JJ, Chi HS.

Leuk Res. 2014 Jan;38(1):65-70. doi: 10.1016/j.leukres.2013.10.016. Epub 2013 Oct 28.

PMID:
24239175
11.

CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia.

Mannelli F, Cutini I, Gianfaldoni G, Bencini S, Scappini B, Pancani F, Ponziani V, Bonetti MI, Biagiotti C, Longo G, Bosi A.

Cytometry B Clin Cytom. 2014 Sep;86(5):340-9. doi: 10.1002/cyto.b.21156. Epub 2014 Feb 5.

12.

Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.

Renneville A, Boissel N, Zurawski V, Llopis L, Biggio V, Nibourel O, Philippe N, Thomas X, Dombret H, Preudhomme C.

Cancer. 2009 Aug 15;115(16):3719-27. doi: 10.1002/cncr.24442.

13.

Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.

Koh Y, Park J, Ahn KS, Kim I, Bang SM, Lee JH, Yoon SS, Soon Lee D, Yiul Lee Y, Park S, Kim BK.

Ann Hematol. 2009 Nov;88(11):1089-97. doi: 10.1007/s00277-009-0733-7. Epub 2009 Mar 19.

PMID:
19296110
14.

Platelet production and related pathophysiology in acute myelogenous leukemia at first diagnosis: prognostic implications.

Trafalis DT, Poulakidas E, Kapsimali V, Tsigris C, Papanicolaou X, Harhalakis N, Nikiforakis E, Mentzikof-Mitsouli C.

Oncol Rep. 2008 Apr;19(4):1021-6.

PMID:
18357391
15.

Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression.

Yasuoka H, Kodama R, Tsujimoto M, Yoshidome K, Akamatsu H, Nakahara M, Inagaki M, Sanke T, Nakamura Y.

BMC Cancer. 2009 Jul 7;9:220. doi: 10.1186/1471-2407-9-220.

16.

Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.

Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Kita Y, Tamotsu K, Hanazono K, Owaki T, Aikou T.

Oncol Rep. 2009 Jan;21(1):65-71.

PMID:
19082444
17.

Biphenotypic characteristics, cell size and prognosis in childhood acute myeloblastic leukemia.

Olcay L, Hiçsönmez G, Ertem U, Okur H, Tuncer AM.

Turk J Pediatr. 1999 Apr-Jun;41(2):219-24.

PMID:
10770661
18.

Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.

Krauter J, Wagner K, Schäfer I, Marschalek R, Meyer C, Heil G, Schaich M, Ehninger G, Niederwieser D, Krahl R, Büchner T, Sauerland C, Schlegelberger B, Döhner K, Döhner H, Schlenk RF, Ganser A.

J Clin Oncol. 2009 Jun 20;27(18):3000-6. doi: 10.1200/JCO.2008.16.7981. Epub 2009 Apr 20.

PMID:
19380453
19.

Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.

Lee JI, Jin BH, Kim MA, Yoon HJ, Hong SP, Hong SD.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 May;107(5):678-84. doi: 10.1016/j.tripleo.2008.12.047. Epub 2009 Mar 9.

PMID:
19272813
20.

Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.

Lee HJ, Kim SW, Kim HY, Li S, Yun HJ, Song KS, Kim S, Jo DY.

Int J Oncol. 2009 Feb;34(2):473-80.

PMID:
19148483

Supplemental Content

Support Center